#8 - Sandra von Meier, Head of Business Development at Debiopharm
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Sandra von Meier, Head of Business Development at Debiopharm
What you'll get out of this episode:
- Sandra's background
- Overview of Debiopharm
- Tell us about Debiopharm’s approach to drug development. How does it work with startups to enhance innovation and expedite clinical trial timelines?
- What steps can companies take to improve patient quality of life in drug development?
- As the world continues to face a global drug shortage, how does Debiopharm bridge the gap between disruptive research and real-world application to ensure patients receive the life-saving drugs they need?
- What’s next for the future of biopharma?
To learn more about Debiopharm: https://www.debiopharm.com/
Full Episode and more info here: https://loom.ly/dkKu8RA
Our sponsors for this episode are:
Sage Growth Partners https://www.sage-growth.com
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/